drugset / Trial / NCT01252758
Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma
RandomizedFactorialDouble-blindTreatment
Summary
The drug product albuterol sulfate DPI, TBS-7, is a single dose inhalation product of albuterol sulfate containing 240 ug albuterol sulphate (200 ug of albuterol) and inhalation grade lactose in a new dry powder delivery system called the Trivair deposition system. Three different doses of albuterol sulfate DPI, TBS-7, will be administered in this dose ranging clinical trial: an optimal dose, 80% of the optimal dose and 50% of the optimal dose and will be compared with placebo and an active comparator.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-04
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salbutamol | Unknown | 200 ug | Inhaled |